A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma

A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma

Item
http://www.wikidata.org/entity/Q34496927
ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects.Reverse-polynomial dilution calibration methodology extends lower limit of quantification and reduces relative residual error in targeted peptide measurements in blood plasma.Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol.Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients.No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects.Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093High-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of raltegravir, dolutegravir and elvitegravir concentrations in human plasma and cerebrospinal fluid samples.Simultaneous quantification of tenofovir, emtricitabine, rilpivirine, elvitegravir and dolutegravir in mouse biological matrices by LC-MS/MS and its application to a pharmacokinetic study.High-Performance Liquid Chromatographic and High-Performance Thin-Layer Chromatographic Method for the Quantitative Estimation of Dolutegravir Sodium in Bulk Drug and Pharmaceutical Dosage Form.Chemical and biochemical characterization and in vivo safety evaluation of pharmaceuticals in drinking water.Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV.Development of an HPLC-UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients.Dolutegravir plus lamivudine maintain HIV-1 suppression through week 48 in a pilot randomized trial.
P2860

A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma

Item
http://www.wikidata.org/entity/Q34496927
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma
@ast
A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma
@en
A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma
@nl
type
label
A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma
@ast
A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma
@en
A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma
@nl
prefLabel
A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma
@ast
A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma
@en
A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P698
P932
P356
P1433
P1476
A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma
@en
P2093
P2860
P304
P31
P356
10.1016/J.JCHROMB.2013.11.054
P478
P577
P698
P932